According to Organovo's latest financial reports and stock price the company's current Operating Margin is -591.52%. At the end of 2022 the company had an Operating Margin of -765.27%.
Year | Operating Margin | Change |
---|---|---|
2022 | -765.27% | |
2020 | -977.91% | 10.83% |
2019 | -882.37% | 15.15% |
2018 | -766.26% | -15.64% |
2017 | -908.37% | -65.08% |
2016 | -2,600.94% | -50.63% |
2015 | -5,268.13% | -22.72% |
2014 | -6,816.62% | |
2012 | -3,547.62% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
General Electric GE | -1.37% | -99.77% | ๐บ๐ธ USA |
3M MMM | -9.39% | -98.41% | ๐บ๐ธ USA |
Intuitive Surgical ISRG | 25.82% | -104.37% | ๐บ๐ธ USA |
United Therapeutics UTHR | 49.09% | -108.30% | ๐บ๐ธ USA |
Stratasys SSYS | -11.00% | -98.14% | ๐ฎ๐ฑ Israel |
3D Systems DDD | -22.45% | -96.20% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.